bimagrumab glp 1 GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates Trial suggests GLP-1 combo therapy

Read more #Endocrinology #HormoneHealth #ESE #ESPE #EndoCompass #RareDisease #Diabetes #Thyroid #Obesity To view or add a comment, sign in This week in #DiabetesNews: A new @CUAnschutz article shares researcher's discoveries on how high-fat diets induce insulin resistance and disrupt the signaling path between the pituitary gland and ovaries

A review of the literature on drug intervention for disulfidptosis target genes and signaling pathways may provide new directions for research on CNS therapy

Written by [email protected]

The state treasurer projected the class of drugs would cost the state more than $170 million this year, with costs jumping to more than $1 billion over the next six years